Trifluoroacetyl-HYNIC peptides: Synthesis and 99mTc radiolabeling

Journal of Medicinal Chemistry

Volumn 50, Issue 6, 2007, Pages 1418-1422

  Surfraz, M Bashir Uddin ^a   King, Robert ^b   Mather, Stephen J ^b   Biagini, Stefano C G ^a   Blower, Philip J ^c  

^a UNIVERSITY OF KENT   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRAZINE DERIVATIVE; N ALPHA 9 FLUORENYLMETHOXYCARBONYL N EPSILON (TERT BUTOXYHYDRAZINONICOTINYL)LYSINE; N ALPHA 9 FLUORENYLMETHOXYCARBONYL N EPSILON (TERT BUTOXYHYDRAZINONICOTINYL)LYSINE TC 99M; NICOTINE DERIVATIVE; TECHNETIUM 99M; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; PEPTIDE SYNTHESIS; SOLID;

GASTRINS; HYDRAZINES; HYDROLYSIS; ISOTOPE LABELING; NICOTINIC ACIDS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RADIOPHARMACEUTICALS; TECHNETIUM; TRIFLUOROACETIC ACID;

EID: 33947646516     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061274l     Document Type: Article

References (23)

1. Abrams, M. J.; Juweid, M.; Tenkate, C. I.; Schwartz, D. A.; Hauser, M. M.; Gaul, F. E.; Fuccello, A. J.; Rubin, R. H.; Strauss, H. W.; Fischmann, A. J. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 1990, 31, 2022-2028.
2. Steffen, M. J.; Oosterwijk, E.; Kranenborg, M. H. G. C.; Manders, J. M. B.; Debruyne, F. M. J.; Corstens, F. H. M.; Boerman, O. C. In vivo and in vitro characterizations of three Tc-99m labeled monoclonal antibody G250 preparations. J. Nucl. Med. 1984, 40, 829-836.
3. Verbeke, K.; Hjelstuen, O.; Debrock, E.; Cleynhens, B.; De Roo, M.; Verbruggen, A. Comparative evaluation of Tc-99m-Hynic-HSA and Tc-99m-MAG3-HSA as possible blood pool agents. Nucl. Med. Commun. 1995, 16, 942-957.
4. Ultee, M. E.; Bridger, G. J.; Abrams, M. J.; Longley, C. B.; Burton, C. A.; Larsen, S. K.; Henson, G. W.; Padmanabhan, S.; Gaul, F. E.; Schwartz, D. A. Tumor imaging with Tc-99m labeled hydrazinonicotinamide-Fab′ conjugates. J. Nucl. Med. 1997, 38, 133-138.
5. Blankenberg, F. G.; Katsikis, P. D.; Tait, J. F.; Davis, R. E.; Naumovski, L.; Ohtsuki, K.; Kopiwoda, S.; Abrams, M. J.; Darkes, M.; Robbins, R. C.; Maecker, H. T.; Strauss, H. W. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 1998, 1998, 6349-6354.
6. van der Laken, C. J.; Boerman, O. C.; Oyen, W. J. G.; van der Ven, M. T. P.; Edwards, D. S.; Barrett, J. A.; van der Meer, J. W. M.; Corstens, F. H. M. Technetium-99m labeled chemotactic peptides in acute infection and sterile inflammation. J. Nucl. Med. 1997, 38, 1310-1315.
7. Ono, M.; Arano, Y.; Mukai, T.; Uehara, T.; Fujioka, Y.; Ogawa, K.; Namba, S.; Nakayama, M.; Saga, T.; Konishi, J.; Horiushi, K.; Yokoyama, A.; Saji, H. Plasma binding of Tc-99m-labeled hydrazino nicotinamide derivatised polypeptides and peptides. Nucl. Med. Biol. 2001, 28, 155-164.
8. Eisenhut, M.; Mohammed, A.; Mier, W.; Schoensiegel, F.; Friebe, M.; Mahmood, A.; Jones, A. G.; Haberkorn, U. Melanoma uptake of Tc-99m complexes containing the N-(ε-diethylaminoethyl)benzamide structural element. J. Med. Chem. 2002, 45, 5802-5805.
9. Rajopadhye, M.; Harris, T. D.; Yu, K.; Glowacka, D.; Damphouse, R. P.; Barrett, J. A.; Hemingway, J.; Edwards, D. S.; Carroll, T. Synthesis, evaluation and Tc-99m complexation of a hydrazinonicotinyl conjugate of a GPIIb/IIIa antagonist cyclic peptide for detection of deep vein thrombosis. Bioorg. Med. Chem. Lett. 1997, 7, 955-960.
10. Liu, S.; Edwards, D. S.; Looby, R. J.; Harris, A. R.; Poirier, M. J.; Barrett, J. A.; Hemingway, J.; Carroll, T. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with Tc-99m using aminocarboxylates as coligands. Bioconjugate Chem. 1996, 7, 63-71.
11. Greenland, W. E. P.; Howland, K.; Hardy, J.; Fogelman, I.; Blower, P. J. Solid phase synthesis of peptide radiopharmaceuticals using Fmoc-N- ε-(Hynic-Boc)-lysine, a technetium binding amino-acid: application to Tc-99m-labeled salmon calcitonin. J. Med. Chem. 2003, 46, 1751-1757.
12. Schwartz, D. A.; Abrams, M. J.; Hauser, M. M.; Gaul, F. E.; Larsen, S. K.; Rauh, D.; Zubieta, J. A. Preparation of hydrazino-modified proteins and their use for the synthesis of technetium-99m-protein conjugates. Bioconjugate Chem. 1991, 2, 333.
13. 99mTc labeling of Fab′ monoclonal antibody fragments. Bioconjugate Chem. 1996, 7, 255.
14. Nock, B. A.; Maina, T.; Behe, M.; Nikolopoulou, A.; Gotthardt, M.; Schmitt, J. S.; Behr, T. M.; Macke, H. R. CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs. J. Nucl. Med. 2005, 46, 1727-1736.
15. Reubi, J. C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003, 24, 389-427.
16. Behe, M.; Behr, T. M. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Biopolymers 2002, 66, 399-418.
17. Smith, J. P.; Stanley, W. B.; Verderame, M. F.; Zagon, I. S. The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer. Pancreas 2004, 29, 271-277.
18. Biagini, P.; Monges, G.; Vuaroqueaux, V.; Parriaux, D.; Cantaloube, J. F.; De Micco, P. The human gastrin/cholecystokinin receptors: type B and type C expression in colonie tumors and cell lines. Life Sci. 1997, 61, 1009-1018.
19. McWilliams, D. F.; Watson, S. A.; Crosbee, D. M.; Michaeli, D.; Seth, R. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut 1998, 42, 795-798.
20. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nα-His)acetic acid-modified [D-Glu1]-minigastrin. Bioconjugate Chem. 2004, 15, 864-871.
21. See Supporting Information.
22. Harris, T. D.; Sworin, M.; Williams, N.; Rajopadhye, M.; Damphouse, R. P.; Glowacka, D.; Poirier, M. J.; Yu, K. Synthesis of stable hydrazones of a hydrazinonicotinyl-modified peptide for the preparation of Tc-99m-labeled radiopharmaceuticals. Bioconjugate Chem. 1999, 10, 808-814.
23. Bentley, T. W.; John, A. J.; Johnstone, R. A. W. Trapping and identification of free radicals in the oxidation of some substituted hydrazines. J. Chem. Soc., Perkin Trans. 2 1973, 1039-1044.